Decoy Therapeutics Inc
(DCOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,541 | -2,667 | -1,710 | -5,576 | -4,112 |
| Depreciation Amortization | 3 | 2 | 1 | 4 | 3 |
| Accounts payable and accrued liabilities | 27 | 338 | 255 | 334 | -437 |
| Other Working Capital | -233 | 564 | 493 | 772 | 103 |
| Other Operating Activity | 52 | -281 | -221 | -60 | 660 |
| Operating Cash Flow | $-3,691 | $-2,044 | $-1,182 | $-4,525 | $-3,783 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -200 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-200 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,488 | 626 | 655 | 1,527 | 1,527 |
| Other Financing Activity | -222 | -222 | -110 | -467 | -360 |
| Financing Cash Flow | $6,266 | $404 | $546 | $1,060 | $1,167 |
| Beginning Cash Position | 2,435 | 2,435 | 2,435 | 5,900 | 5,900 |
| End Cash Position | 4,810 | 795 | 1,798 | 2,435 | 3,284 |
| Net Cash Flow | $2,375 | $-1,640 | $-636 | $-3,465 | $-2,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,691 | -2,044 | -1,182 | -4,525 | -3,783 |
| Free Cash Flow | -3,691 | -2,044 | -1,182 | -4,525 | -3,783 |